ArticleFrontiers in immunology2022

A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma.

Shujia Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.